Publications
Article · Journal Of Advanced Pharmacy Education And Research · January 1, 2024
In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
Timur M. Saliev, Shynar B. Tanabayeva, Neilya Ussebayeva, Slu Izmailova, Bauyrzhan A. Umbayev, Gani Akhanov
Abstract
Since the outbreak of the COVID-19 pandemic caused by the SARS-CoV-2 virus, there has been a pressing need for effective and accessible antiviral agents. Aminocaproic acid (Epsilon-aminocaproic acid, EACA), known primarily for its antifibrinolytic properties, has recently been in the spotlight for its potential cytotoxic and antiviral capabilities. This study aims to evaluate the in vitro cytotoxicity and antiviral activity of EACA against SARS-CoV-2.An in-depth in vitro analysis was conducted i
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMedicinal Plant Researchepsilon-aminocaproic acidSARS-CoV-2COVID-19 pandemic
More by Timur Saliev
- Beyond Traditional Risk Scores: Artificial Intelligence in Coronary Plaque Characterization and Personalized Atherosclerosis ManagementJournal of Cardiovascular Development and Disease · 2026
- Age-Metabolic Profile of Lower Serum Estradiol Among Women in Kazakhstan: A Large National Survey-Based Analytical StudyInternational Journal of Environmental Research and Public Health · 2026
- Sleep Quality and Its Sociodemographic, Behavioural, Clinical, and Regional Correlates Among Adults in Kazakhstan: A National Cross-Sectional SurveyClocks & Sleep · 2026
- Radioprotective Effect of ε-Aminocaproic Acid in Acute Total-Body Gamma Irradiation in RatsLife · 2026